Dragon Jade International Appoints Medical Advisors

HONG KONG, July 13, 2016 /PRNewswire/ -- Dragon Jade International Limited (OTC:DGJI) is very pleased to announce that Dr. Francois Yeung FONG, Dr. Shuk Dai MOK and Dr. Edward Shiu Fai LIU have been appointed as Medical Advisors of the Medical Advisory Board of our Group.

As a medical group committed to developing and distributing medical and health products that improve people's lives, we greatly value the physician's perspective on the development of medical and healthcare services.  Therefore, we have established a Medical Advisory Board to offer advices on the screening of potential medical projects and the exploration of new medical products aiming to enhance the quality of medical services in the community.  Advice from the Medical Advisory Board plays an important role in the implementation of high standard hospital management systems as well as providing decent personnel training for hospitals in mainland China, and preparation for integration into the global community.  Our Medical Advisors are serving as drug and health food advisors for various regions including Hong Kong, Singapore and Taiwan, etc.  They will also participate in speaking tours, seminars and lectures on western medical expertise in the Asia-Pacific region.

Dr. Francois Yeung FONG graduated from Monash University in Australia with a MBBS and Medical Science degree in 1994.  Dr. Fong received further training in family medicine and sexual health in Australia.  He obtained a Master in Family Medicine from Monash University, Master in Sexual Health from University of Sydney and Fellow of the Royal Australian College of Family Physician.  He had been a lecturer in General Practice and post-graduate supervisor in Counseling at Monash University as well as post-graduate supervisor for the University of Sydney sexual health program.  Dr. Fong is currently a practicing family and sexual health physician and is the Managing Director of Neo-Health Group.  Dr. Fong is also serving as honorary assistant professor of The University of Hong Kong and The Chinese University of Hong Kong.

Dr. Shu Dai MOK graduated from The University of Hong Kong in 1974.  After receiving training in general surgery at the Queen Elizabeth Hospital in Hong Kong, Dr. Mok became a Fellow of the Royal College of Physicians and Surgeons of Glasgow, Royal College of Surgeons of Edinburgh and the Royal Australasian College of Surgeons.  He is also a Founding Fellow of the College of Surgeons of Hong Kong and The Hong Kong Academy of Medicine.  As part of his post-fellowship training, he attended training courses at various overseas institutions including the Institute of Urology in London and the St. Mark's Hospital for Cancer, Fistula and other Diseases of the Rectum.  Before entering private practice in 1988, Dr. Mok served as Senior Medical Officer and Honorary Clinical Lecturer at the Prince of Wales Hospital, the main teaching hospital of the Faculty of Medicine of The Chinese University of Hong Kong.  His main specialty is general surgery with a particular interest in hepato-pancreato-biliary surgery.

Dr Edward Shiu Fai LIU graduated from The University of Hong Kong in 1993 and started his medical career in Hong Kong from early 1995.  He had been serving in the Department of Clinical Oncology of Tuen Mun Hospital in Hong Kong for 16 years with his profession and specialty.  After completing further education, Dr. Liu became a Fellow of the Royal College of Radiologists in 2007 and obtained a Bachelor of Chinese Medicine in 2008.  After receiving intensive training from The Erasmus University Medical Center in Rotterdam in 2009, he became a member of The European Society for Hyperthermic Oncology.  He is an extraordinary clinical oncologist who is also equipped with a Chinese medicine practitioner qualification.

About Dragon Jade

Dragon Jade International Limited and its subsidiaries ("the Group") focused on identifying, developing and marketing the next generation of herbal and natural products that improve people's lives. The Group is positioned to leverage proven resources that allow us to assess, enhance and realize the commercial potential of herbal and biotechnological discoveries. The Group strives to develop and offer to the market the broadest selection of cost-effective healthy living products, which shall deliver substantial returns to investors.  More information on Dragon Jade, visit the Company's website: www.dgjigroup.com.

Safe Harbor Statement

This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as the Company "believes," "expects," "anticipates," "foresees," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

SOURCE Dragon Jade International Ltd

Related Links

http://www.dgjigroup.com/